- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04419129
Comparison of Functional Recovery Between Mobile Bearing Unicompartmental Knee Arthroplasty and Total Knee Arthroplasty
August 29, 2021 updated by: Boonchana Pongcharoen, Thammasat University
Department of Orthopedics, Faculty of Medicine, Thammasat University
The total knee replacement (TKA) has shown excellent survival.
However, some patients were up to 20%, they still had pain and make them dissatisfy after operation.
The medial unicompartmental knee arthroplasty (UKA) also has shown excellent survivorship.
The patient who underwent UKA fell like normal knee because restoring natural kinematic and biomechanic compare to TKA.
However, The previous studies did not include the same characteristic of patient in their studies.
Therefor, UKA should be better than TKA.
This study will compare TKA to mobile bearing medial UKA or Oxford medial UKA.
The mobile bearing UKA is different to fixed bearing UKA.
The mobile bearing UKA will be back knee alignment to pre-disease stage, restore knee stability and restore natural knee kinematic and biomechanic.
Therefore, patients who underwent mobile bearing UKA will feel like normal knee and restore function to near or nearly normal.
The measurement of clinical outcome after knee arthroplasty is questionable.
The self-report questionnaire was used in the past.
However, this score can not estimate the true function of patients.
The patient have shown high score, but they still had pain and did not show satisfy after operation.The performance-based test such as 2-minute walk test (2MWT), 6-minute walk test (6MWT) and Timed get-up-and-go test (TUG) should show the exactly clinical outcome of patient following knee arthroplasty compare to self-report questionnaire.
Today, no randomized controlled trial study to compare performance-based test between TKA and mobile bearing UKA.
Therefor, this study will compare 2MWT and TUG between TKA and mobile bearing UKA in medial OA knee.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The inclusion criteria were patients with medial of the knee with an Alhback score of 2, 3 or 4, those who were older than 40 years of age, those with a range of motion (ROM) > 90°, those with a varus deformity < 25°, and those with a flexion contracture < 20°.
They were randomized into 2 groups using computer program.
Group I was 50 UKAs and group II was 50 TKAs.
All patients in group I received medial mobile-bearing UKA (Oxford® UKA; Zimmer Biomet, Inc, Warsaw, IN, USA) and group II received posterior stabilized fixed bearing total knee arthroplasty (Vanguard®; Zimmer Biomet, Inc, Warsaw, IN, USA).
The exclusion criteria were patients with a diagnosis of spontaneous osteonecrosis of the knee (SPONK), intraoperative anterior cruciate ligament (ACL) insufficiency or completely rupture of ACL, inflammatory joint disease, gout, posttraumatic arthritis, or primary patellofemoral arthritis.The recorded baseline patient characteristics included age and sex and the knee side, Knee Society Score (KSS), Oxford Knee Score (OKS), Knee Injury and Osteoarthritis Outcome Score (KOOS),(2MWT), (6MWT), (TUG), body mass index (BMI), degree of varus deformity, degree of flexion contracture, genu recurvatum, and ROM.
Patients were followed at 6 weeks, 3 months, 6 months, and 1 year and then annually thereafter.
At each follow-up, the following data were recorded: Joint Forgotten Score (JFS), KSS, OKS, Knee Injury and Osteoarthritis Outcome Score (KOOS), Kujala score, (2MWT), (TUG), ROM and knee alignment.
In addition, the following knee X-rays were performed: anteroposterior (AP) and lateral standing, skyline and long-leg views; from these, the tibiofemoral angles were measured.
Complications such as infection, component loosening, fractures, and bearing dislocations were also recorded.
We determined differences in the KSS, OKS, KOOS, JFS, Kujala score,(2MWT), (TUG),ROM, tibiofemoral angle, flexion contractures, and genu recurvatum using Student's t tests.
All analyses were two sided, and a p value of ≤ 0.05 denoted statistical significance.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Pathum Thani, Thailand, 12120
- Boonchana Pongcharoen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- anteromedial OA knee
Exclusion Criteria:
- varus deformity > 15 degrees
- ROM < 90 degrees
- fixed varus deformity
- post-traumatic arthritis
- inflammatory arthritis
- anterior cruciate ligament insufficiency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Mobile bearing unicompartmental knee arthroplasty
50 mobile bearing UKA
|
knee arthroplasty
|
|
ACTIVE_COMPARATOR: posterior stabilized fixed bearing total knee arthroplasty
50 posterior stabilized fixed bearing cemented total knee arthroplasty
|
knee arthroplasty
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
2 minutes walk test (2MWT)
Time Frame: 2 years
|
measurement of endurance that assesses walking distance over 2 minutes
|
2 years
|
|
time up and go test (TUG)
Time Frame: 2 years
|
It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee Society Score
Time Frame: 2 years
|
The standard clinical evaluation system for reporting results for patients undergoing unicompartmental knee arthroplasty
|
2 years
|
|
Oxford knee score
Time Frame: 2 years
|
The standard clinical evaluation system for reporting results for patients undergoing unicompartmental knee arthroplasty
|
2 years
|
|
Forgotten Joint Score
Time Frame: 2 years
|
The standard clinical evaluation system for reporting results for patients undergoing unicompartmental knee arthroplasty
|
2 years
|
|
Kujala score
Time Frame: 2 years
|
The standard clinical evaluation system for reporting results for patients undergoing unicompartmental knee arthroplasty
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Boonchana Pongcharoen, MD, Faculty of Medicine, Thammasat University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2017
Primary Completion (ACTUAL)
December 1, 2020
Study Completion (ACTUAL)
December 1, 2020
Study Registration Dates
First Submitted
May 28, 2017
First Submitted That Met QC Criteria
June 3, 2020
First Posted (ACTUAL)
June 5, 2020
Study Record Updates
Last Update Posted (ACTUAL)
August 31, 2021
Last Update Submitted That Met QC Criteria
August 29, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- ThmmasatU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Reported Outcome Measure
-
Nordlandssykehuset HFUniversity Hospital of North Norway; University of Tromso; Helgelandssykehuset...RecruitingPatient Reported Outcome MeasureNorway
-
Haukeland University HospitalUllevaal University Hospital; Ostfold Hospital Trust; Helse Stavanger HF; St. Olavs... and other collaboratorsRecruitingAnkle Fractures | Treatment Outcome | Syndesmotic Injuries | Patient Reported Outcome Measure | Posterior Malleolus FracturesNorway
-
Massachusetts Institute of TechnologyMillennium Pharmaceuticals, Inc.CompletedPatient Reported Outcome Measures | ComplianceUnited States
-
University Medical Center GoettingenRecruitingSupportive Care | Patient Related Outcome Measures | Patient Reported Outcome (PRO)Germany
-
Manuela EicherRecruitingPatient Reported Outcome Measures | Patient SafetySwitzerland
-
Kocaeli City HospitalNot yet recruitingPatient Reported Outcome Measures | Postoperative Recovery
-
Orthosensor, Inc.CompletedPatient Engagement | Knee Arthroplasty | Patient-Reported Outcome Measures (PROMs)United States
-
Guangdong Provincial People's HospitalNot yet recruitingPatient Reported Outcome Measures | Pulmonary Surgical ProceduresChina
-
Ankara UniversityCompletedMajor Abdominal Surgery | Patient-reported OutcomeTurkey
-
Dr Robert BoweNobel BiocareNot yet recruitingDental Implant | Dental Restorations | Patient Experience | Patient Reported Outcome
Clinical Trials on Oxford UKA
-
Regional Hospital HolstebroCompletedKnee Osteoarthritis | Knee Replacement | RSA
-
Thammasat UniversityCompleted
-
Medacta USAWithdrawnOsteoarthritisUnited States
-
Orthopaedic Innovation CentreActive, not recruiting
-
Zimmer BiometCompletedOsteoarthritis, Knee | Avascular Necrosis of the Medial Femoral CondyleUnited States
-
Istituto Ortopedico RizzoliEnrolling by invitationCruciate Ligament Rupture | Knee Arthritis OsteoarthritisItaly
-
Istituto Ortopedico RizzoliSmith & Nephew, Inc.Active, not recruitingLoosening, ProsthesisItaly
-
Oxford University Hospitals NHS TrustCompletedOsteoarthritis, Knee
-
Washington University School of MedicineCompleted
-
Göteborg UniversityCompletedArthroplasty, Replacement, KneeSweden